Monsanto recently broke ground on a nearly one billion-dollar plant upgrade as the company plans to provide farmers tools to fight the broadleaf weeds that have become more prevalent in recent years.
Chief Technology Officer Robb Fraley says even though the company awaits approval for its merger with Bayer, research and development remain top priorities.
Fraley says Monsanto will invest about one-point-five billion dollars this year in research and development. That’s impressive in ag circles, but he says pharmaceutical companies will invest more than eight billion. He adds the pending merger will allow them to grow their commitment to innovation.
Fraley will speak Thursday at the Illinois Soybean Summit in Peoria. For more information on the summit visit ilsoy-dot-com, slash, summit.